[go: up one dir, main page]

GR3019112T3 - Porcine reproductive respiratory syndrome vaccine and diagnostic. - Google Patents

Porcine reproductive respiratory syndrome vaccine and diagnostic.

Info

Publication number
GR3019112T3
GR3019112T3 GR960400533T GR960400533T GR3019112T3 GR 3019112 T3 GR3019112 T3 GR 3019112T3 GR 960400533 T GR960400533 T GR 960400533T GR 960400533 T GR960400533 T GR 960400533T GR 3019112 T3 GR3019112 T3 GR 3019112T3
Authority
GR
Greece
Prior art keywords
respiratory syndrome
porcine reproductive
diagnostic
reproductive respiratory
syndrome vaccine
Prior art date
Application number
GR960400533T
Other languages
Greek (el)
Inventor
Nicolaas Visser
Volker Ohlinger
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207942&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3019112(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of GR3019112T3 publication Critical patent/GR3019112T3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention is directed to the identification of the causative agent of Porcine Reproductive Respiratory Syndrome virus and vaccines derived therefrom. The present invention is also directed to viral antigens produced by tissue culture cells infected with this virus, and the use of such antigens in diagnostics.
GR960400533T 1991-10-14 1996-02-27 Porcine reproductive respiratory syndrome vaccine and diagnostic. GR3019112T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91202646 1991-10-14
PCT/EP1992/002331 WO1993007898A1 (en) 1991-10-14 1992-10-09 Porcine reproductive respiratory syndrome vaccine and diagnostic

Publications (1)

Publication Number Publication Date
GR3019112T3 true GR3019112T3 (en) 1996-05-31

Family

ID=8207942

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400533T GR3019112T3 (en) 1991-10-14 1996-02-27 Porcine reproductive respiratory syndrome vaccine and diagnostic.

Country Status (12)

Country Link
US (1) US6033844A (en)
EP (1) EP0610250B2 (en)
JP (1) JPH07501049A (en)
AT (1) ATE131067T1 (en)
AU (1) AU2684792A (en)
CA (1) CA2121241C (en)
DE (1) DE69206631T2 (en)
DK (1) DK0610250T4 (en)
ES (1) ES2083764T5 (en)
GR (1) GR3019112T3 (en)
HU (1) HU220113B (en)
WO (1) WO1993007898A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103460C (en) * 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6251397B1 (en) * 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
ATE197314T1 (en) * 1993-02-08 2000-11-15 Bayer Ag METHOD FOR PRODUCING THE SWINE VIRUS CAUSING REPRODUCTIVE AND RESPIRATORY SYNDROME AND ITS USE AS A VACCINE.
ES2074950B1 (en) * 1993-09-17 1996-03-16 Iberica Cyanamid VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
DE4407489A1 (en) * 1994-03-07 1995-09-14 Bayer Ag Vaccine for the prevention of respiratory and reproductive diseases of the pig
ES2165405T3 (en) * 1994-04-11 2002-03-16 Akzo Nobel Nv EUROPEAN VACCINE BREEDS OF THE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV).
DK53595A (en) * 1994-05-13 1995-11-14 Iberica Cyanamid Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
ES2102971B1 (en) * 1996-01-25 1998-03-01 Hipra Lab Sa NEW ATTENUATED STRAIN OF THE VIRUS CAUSING THE RESPIRATORY AND REPRODUCTIVE SYNDROME (PRRS), THE VACCINES AND DIAGNOSTIC MEDIA OBTAINABLE WITH THE SAME AND THE PROCEDURES FOR ITS OBTAINING.
CO4600644A1 (en) * 1996-03-01 1998-05-08 Schering Corp VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME
US5866401A (en) * 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
DK0835930T3 (en) * 1996-10-09 2001-06-18 Akzo Nobel Nv European vaccine strains of porcine reproductive and respiratory syndrome virus. (PRRSV)
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0980387B1 (en) 1997-05-06 2007-06-27 Boehringer Ingelheim Vetmedica Gmbh Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
UA78180C2 (en) 1997-10-03 2007-03-15 Меріаль Porcine circovirus, vaccines and diagnostic reagents
JP3961222B2 (en) 1999-03-08 2007-08-22 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー PRRSV vaccine
AU4482200A (en) 1999-04-22 2000-11-10 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
US6740490B2 (en) 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
US6841364B2 (en) 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
RU2007101725A (en) * 2004-06-18 2008-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) IDENTIFICATION OF VIRUS-INFECTED AND VIRUS-VACCINATED ORGANISMS
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
SI2281829T1 (en) 2004-12-30 2015-03-31 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions for use in a method of preventing PCV2 infection
BRPI0606539A2 (en) 2005-01-13 2009-06-30 Boehringer Ingelheim Vetmedica Gmbh improved prrs vaccines
KR101321153B1 (en) 2005-06-24 2013-10-22 리전츠 오브 더 유니버스티 오브 미네소타 Prrs viruses, infectious clones, mutants thereof, and methods of use
CN103536914B (en) 2005-12-29 2015-11-11 贝林格尔.英格海姆维特梅迪卡有限公司 Multivalent pcv 2 immunogenic compositions and the method preparing such composition
WO2008013918A2 (en) * 2006-07-26 2008-01-31 Myelin Repair Foundation, Inc. Cell cycle regulation and differentiation
MX2009007457A (en) 2007-01-12 2009-08-12 Univ Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus.
US7666585B2 (en) * 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
ES2564202T3 (en) * 2008-02-29 2016-03-18 Universiteit Gent Method to determine the antigenicity of an inactivated PRRSV virus
TWI627281B (en) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 Methods of reducing viricidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity
AU2012217169B2 (en) 2011-02-17 2016-08-11 Boehringer Ingelheim Vetmedica Gmbh Novel european PRRSV strain
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737058A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
UA114504C2 (en) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (en) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс PCV AND MYCOPLASMA HYOPNEUMONIA COMBINED VACCINE
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
DK3591042T5 (en) 2013-12-20 2024-09-02 Boehringer Ingelheim Vetmedica Gmbh PRRS virus variant, cDNA clone of European PRRS virus and uses thereof
ES2778649T3 (en) 2015-08-31 2020-08-11 Boehringer Ingelheim Vetmedica Gmbh Pestiviral vaccines for congenital tremors
EP3389706A1 (en) 2015-12-14 2018-10-24 Boehringer Ingelheim Vetmedica, Inc. Hybrid core feline vaccines
PH12021552477A1 (en) 2019-04-04 2022-07-18 Boehringer Ingelheim Animal Health Usa Inc Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof
KR20230044474A (en) 2020-07-24 2023-04-04 베링거 인겔하임 애니멀 헬스 유에스에이 인크. combination swine vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452902A (en) * 1981-11-19 1984-06-05 Labsystems Oy Method and equipment for the measurement of properties of a liquid
CA2103460C (en) * 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
AU2508492A (en) * 1991-08-26 1993-03-16 David Allen Benfield Sirs vaccine and diagnosis method
MX9204885A (en) * 1991-08-26 1994-05-31 Boehringer Animal Health Inc VACCINE COMPOSITION INCLUDING VIRUSES OF INFERTILITY AND RESPIRATORY SYNDROME OF PIGS.
AU2696792A (en) * 1991-09-16 1993-04-27 David A Benfield Vaccine for mystery swine disease and method for diagnosis thereof
ES2165405T3 (en) * 1994-04-11 2002-03-16 Akzo Nobel Nv EUROPEAN VACCINE BREEDS OF THE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV).

Also Published As

Publication number Publication date
EP0610250A1 (en) 1994-08-17
HU9401056D0 (en) 1994-07-28
ES2083764T3 (en) 1996-04-16
ES2083764T5 (en) 2009-04-01
HUT69803A (en) 1995-09-28
DE69206631D1 (en) 1996-01-18
ATE131067T1 (en) 1995-12-15
EP0610250B2 (en) 2008-10-29
AU2684792A (en) 1993-05-21
WO1993007898A1 (en) 1993-04-29
US6033844A (en) 2000-03-07
EP0610250B1 (en) 1995-12-06
DE69206631T2 (en) 1996-05-15
CA2121241C (en) 2007-12-04
DK0610250T3 (en) 1996-04-09
CA2121241A1 (en) 1993-04-29
DK0610250T4 (en) 2009-03-02
HU220113B (en) 2001-11-28
JPH07501049A (en) 1995-02-02

Similar Documents

Publication Publication Date Title
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
NO871313L (en) PROCEDURE FOR THE PREPARATION OF VIRUS VACCINE.
RU94042386A (en) Vaccine against hepatitis containing 3-o-deacylated monophosphoryl-lipid a, use of hepatitis antigen for preparing the preparation for hepatitis treatment, method of hepatitis treatment
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
BR9608535A (en) Virulent agent associated with ignored pig disease
FR07C0073I2 (en) PAPILLOMAVIRUS VACCINE
EP0061974A3 (en) New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process
MXPA01010681A (en) Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142.
FI905184A0 (en) CHIMERIC GLYCOPROTEINER SOM INNEHAOLLER IMMUNOGENIC DELAR AV HUMAN PARAINFLUENSA VIRUS TYPE 3.
CA2144855A1 (en) Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
JPS5740412A (en) Manufacture of virus antigen
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
TW340873B (en) Chicken anaemia agent vaccine
DE69533067D1 (en) HEPATIS E-VIRUS ANTIGENE AND THEIR USE
GR3007856T3 (en)
WO1994000586A3 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
AU3830995A (en) Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
OA09653A (en) Rubella peptides
NO175846C (en) Method of obtaining an immunogen
Jilg et al. Prolonged immunity after late booster doses of hepatitis B vaccine
EP0250128A3 (en) Novel virus isolated from patients with aids
ES2074965B1 (en) RECOMBINANT MUTANT VIRUSES OF INFECTIOUS BOVINE RHINOTRACHEITIS AND VACCINES THAT CONTAIN IT.
ATE86308T1 (en) HUMAN B-LYMPHOTROPIC VIRUS (HBLV), ISOLATION AND PRODUCTS.
Krugman Live attenuated measles vaccine: Its development and characteristics.